Salix To Pay $210M To Settle Stock Inflation Class Action
By Cara Bayles ( March 27, 2017, 6:50 PM EDT) -- Shareholders in a proposed class action asked a New York federal court on Friday for preliminary approval of a $210 million settlement to end a lawsuit accusing Salix Pharmaceuticals Ltd. of inflating stock prices by knowingly misrepresenting the company's wholesale inventory levels....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.